4-氨基-N-(2-氰乙基)-1-甲基吡咯-2-甲酰胺 | 97950-77-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-氨基-N-(2-氰乙基)-1-甲基吡咯-2-甲酰胺
• 英文名称: 3-(1-methyl-4-aminopyrrole-2-carboxamido)propionitrile
• 英文别名: 4-Amino-1-methyl-pyrrol-carbonsaeure-(2)-(2-cyanethylamid)；4-Amino-N-(2-cyanoethyl)-1-methyl-1H-pyrrole-2-carboxamide；4-amino-N-(2-cyanoethyl)-1-methylpyrrole-2-carboxamide
• CAS: 97950-77-1
• 化学式: C₉H₁₂N₄O
• 分子量: 192.22
• InChiKey: IYEVFPGJVJXRJO-UHFFFAOYSA-N

物化性质

• 沸点：
  492.4±40.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-氨基-N-(2-氰乙基)-1-甲基吡咯-2-甲酰胺 在 palladium on activated charcoal 盐酸 、 氨 、 氢气 、 溶剂黄146 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 34.0h， 生成 3-<1-methyl-4-<4-methyl-2-(1-methyl-4-(formylamino)-pyrrole-2-carboxamido)thiazole-5-carboxamido>pyrrole-2-carboxamido>propionamidine hydrochloride
  参考文献：
  名称：

  Synthesis of novel thiazole-containing DNA minor groove binding oligopeptides related to the antibiotic distamycin

  摘要：

  DOI：

  10.1021/jo00289a057
• 作为产物：
  描述：

  1-甲基-4-硝基吡咯-2-羧酸 在 palladium on activated charcoal 氯化亚砜 、 氢气 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 0.08h， 生成 4-氨基-N-(2-氰乙基)-1-甲基吡咯-2-甲酰胺
  参考文献：
  名称：

  Design, synthesis, DNA-binding and cytotoxicity evaluation of new potential combilexines

  摘要：

  Combilexines, compounds in which a DNA intercalator is linked to a minor groove binding component, interact with the DNA in a sequence specific manner to yield in most cases compounds with anticancer activity. A series of new compounds closely related to netropsin in which the two components were linked by an amide group was synthesised as potential combilexines. As some of these compounds showed cytotoxic activity in vitro, an attempt was made to rationalise their mechanism of action. The DNA binding characteristics of the carboxamides were evaluated by thermal denaturation experiments and by ethidium bromide displacement assay. Their ability to inhibit the topoisomerase I was also determined. It was concluded that the new compounds were only weak DNA ligands although able in some cases to inhibit topoisomerase I. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

  DOI：

  10.1016/s0223-5234(02)01349-1

文献信息

• Synthesis of Geometrically Constrained Unsymmetrical Bis(polyamides) Related to the Antiviral Distamycin
  作者：Sanjay K. Sharma、Manju Tandon、J. William Lown

  DOI：10.1002/1099-0690(200006)2000:11<2095::aid-ejoc2095>3.0.co;2-j

  日期：2000.6

  for the strict DNA base-sequence recognition of (AT)4 and (AT)5, respectively, for the oligopeptide minor-groove binding agents netropsin (I) and distamycin (II) leads to proposals for the rational structure modification for altered base recognition. In this paper we report the synthesis of unsymmetrical imidazo-pyrrolo-bis(polyamides), structurally related to the natural antiviral agents distamycin

  分析分别对（AT）4和（AT）5的寡肽小沟结合剂netropsin（I）和distamycin（II）的严格DNA碱基序列识别的结构和立体化学要求导致了对合理的结构修饰，以改变碱基识别。在本文中，我们报告了与天然抗病毒剂双歧霉素在结构上相关且带有非天然（25-27）或天然（31-33）的不对称咪唑并吡咯并双（聚酰胺）的合成）由柔性或刚性接头链接的末端。这是关于在连接的双（聚酰胺）中具有二甲基氨基丙基或am基末端的带有咪唑的结构的合成的首次报道。
• Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation
  作者：J. William Lown、Krzysztof Krowicki、Jan Balzarini、Robert A. Newman、Erik De Clercq

  DOI：10.1021/jm00130a024

  日期：1989.10

  have been synthesized which are structurally related to the natural antiviral antitumor antibiotics netropsin and distamycin bearing two such moieties linked by polymethylene bridges. Cytostatic activity against both human and murine tumor cell lines and their in vitro activity against a range of viruses are reported. Enhanced antiviral activity was obtained against vaccinia virus. As a result of the

  合成了一组寡肽，其在结构上与天然抗病毒抗肿瘤抗生素netropsin和distamycin有关，带有通过聚亚甲基桥连接的两个这样的部分。据报道，对人和鼠肿瘤细胞系均具有细胞抑制活性，并且它们对多种病毒具有体外活性。获得了针对牛痘病毒的增强的抗病毒活性。由于引入了多亚甲基接头[（CH2）n，n = 1、2和6-8]，与母体化合物netropsin和distamycin相比，其抗肿瘤和抗痘苗病毒的活性均显着增强。讨论了这些试剂的生物学活性，既涉及其结构差异，也涉及其与双链DNA的小沟结合。
• Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity
  作者：Pier Giovanni Baraldi、Paolo Cozzi、Cristina Geroni、Nicola Mongelli、Romeo Romagnoli、Giampiero Spalluto

  DOI：10.1016/s0968-0896(98)00205-3

  日期：1999.2

  The design and synthesis of novel benzoic acid mustard (BAM) derivatives of distamycin A bearing one or more pyrazole rings replacing the pyrrole rings of the latter are described. In vitro and in vivo activities against L1210 leukemia are reported and discussed. Some of these compounds show an activity profile comparable to tallimustine 1. All the compounds bearing the pyrazole ring close to the BAM

  本文描述了新型双酚A的苯甲酸芥末（BAM）衍生物的设计和合成，该衍生物带有一个或多个吡唑环替代了后者的吡咯环。报道和讨论了针对L1210白血病的体外和体内活性。这些化合物中的一些表现出与塔莫司汀1相当的活性。与以BAM与吡咯相连的衍生物相比，所有带有靠近BAM部分的吡唑环的化合物均显示出降低的细胞毒性：发生时未观察到相同的作用在寡肽框架的idine末端。
• [EN] PROCESS FOR THE SYNTHESIS OF DISTAMYCIN AND DERIVATIVES THEREOF USING 1-METHYL-4-FORMYLAMINO-2-PYRROLECARBONYL CHLORIDE ITERATIVELY AS AN INTERMEDIATE<br/>[FR] PROCEDE DE SYNTHESE DE DISTAMYCINE ET DE SES DERIVES AU MOYEN DE CHLORURE DE 1-METHYL-4-FORMYLAMINO-2-PYRROLECARBONYLE DE FACON REPETEE EN TANT QU'INTERMEDIAIRE
  申请人：NAXOSPHARMA S R L

  公开号：WO2004106301A1

  公开（公告）日：2004-12-09

  A process for the total synthesis of Distamycin, and synthetic poly-(4 aminopyrrole -2-carboxamide) congeners thereof, using 1-methyl-4­- forinylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate, is provided. The process finds application for both in solution and solid support synthetic technologies.

  提供了一种使用1-甲基-4-吡啶基氨基-2-吡咯烷羧酰氯作为中间体迭代地进行Distamycin的全合成以及合成的聚合物-(4-氨基吡咯-2-羧酰胺)的方法。该方法适用于溶液和固相合成技术。
• Distamycin A analogues as antitumour or antiviral agents
  申请人：Pharmacia S.p.A.

  公开号：US05753629A1

  公开（公告）日：1998-05-19

  The present invention relates to compounds of formula (I) ##STR1## The compounds of the invention are useful as antitumor or antiviral agents.

  本发明涉及式(I)的化合物。##STR1##本发明的化合物可用作抗肿瘤或抗病毒剂。